Refractive Changes after Pharmacologic Resolution of Diabetic Macular Edema – Corrected Proof

Purpose: To determine precisely the mean change in refractive power induced by treatment in patients with diabetic macular edema (DME).Design: Prospective, randomized study.Participants: Fifty eyes of 50 consecutive patients with clinically significant macular edema receiving all 3 types of current state-of-the-art treatment with intravitreal antiedematous substances (ranibizumab, bevacizumab, or triamcinolone).Methods: Patients were followed up at monthly intervals and were treated following a standardized pro re nata regimen according to protocol. Best-corrected visual acuity (BCVA) was determined by certified visual acuity examiners. The refractive power of the treated eyes was determined using a push-plus technique. The change in refraction between baseline (Read more...)

Full Story →